Laboratory monitoring of indices in burnt during infection COVID-19

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The results of laboratory and instrumental studies are analyzed in 46 victims with skin burns of various localization, area and depth of the lesion infected with COVID virus 19 hospitalized in the burn center of Saint-Petersburg Research Institute of Ambulance named after I.I. Dzhanelidze in 2020. The control group included 46 patients with similar severity lesions who were treated at the center in 2018. The data on the general condition of patients, clinical and biochemical blood tests, coagulogram, gas composition, general urine analysis, and X-ray data were assessed. It was found that in the groups of lightly and severely burned and patients in 75.9 and 64.9% of cases, respectively, X-ray examination and computed tomography of the chest organs did not reveal infiltrative changes in the lungs, despite the positive results of virological studies. In the second half of the incubation period, in comparison with the data obtained in the control group, deviations in the following indicators were stated: hemoglobin, hematocrit, leukocytes, neutrophils, lymphocytes, immature granulocytes, erythrocyte sedimentation rate, levels of total protein, creatinine and blood fibrinogen from 1.6% up to 18 times. In other analyzed parameters, no changes were noted. When comparing the data obtained in the second half of the incubation period with the results of laboratory studies of uninfected patients in the group of severely burned patients, significant differences were established among the thrombocyte readings (39.2% less), platelet count (42.9% less), and in the group of lightly burned — the number of erythrocytes (less by 11.8%), hemoglobin (less by 19.4%), hematocrit (less by 16.2%) and eosinophils (less by 71%), total protein (less by 5.6%) and creatinine (less by 12.2%). Providing medical care to patients during the pandemic caused by the new coronavirus infection COVID-19 is a challenge for the healthcare system. The results obtained are the first step towards understanding the features of the course of typical pathological processes caused by burn injury and the new coronavirus infection COVID-19.

About the authors

E. V. Zinoviev

Saint - Petersburg institute of emergency care n.a. I.I.Dzhanelidze

Author for correspondence.
Email: evz@list.ru

doctor of medical sciences

Russian Federation, 3, Budapeshtskaya street, Saint-Petersburg, 192242

Vadim A. Manukovskiy

Saint - Petersburg institute of emergency care n.a. I.I.Dzhanelidze

Email: sekr@emergency.spb.ru

doctor of medical sciences

Russian Federation, 3, Budapeshtskaya street, Saint-Petersburg, 192242

Denis V. Kostyakov

Saint - Petersburg institute of emergency care n.a. I.I.Dzhanelidze

Email: kosdv@list.ru

candidate of medical sciences

Russian Federation, 3, Budapeshtskaya street, Saint-Petersburg, 192242

Vasily N. Tsygan

Military medical academy of S.M. Kirov

Email: vn-t@mail.ru

doctor of medical sciences

Russian Federation, 6G, Akademika Lebedeva street, Saint-Petersburg, 194044

Andrei V. Apchel

Severo-Western Medical Training Center for Postgraduate Education

Email: evz@list.ru

doctor of medical sciences

Russian Federation, Saint Petersburg

Vitaly V. Soloshenko

Saint Petersburg I.I. Dzhanelidze research institute of emergency medicine

Email: vs@gmail.com

doctor of medical sciences

Russian Federation, 3, Budapeshtskaya street, Saint-Petersburg, 192242

Lyudmila P. Pivovarova

Saint Petersburg I.I. Dzhanelidze research institute of emergency medicine

Email: evz@list.ru

doctor of medical sciences

Russian Federation, 3, Budapeshtskaya street, Saint-Petersburg, 192242

Dmitry A. Ternovoy

Saint Petersburg I.I. Dzhanelidze research institute of emergency medicine

Email: evz@list.ru

resident physician

Russian Federation, 3, Budapeshtskaya street, Saint-Petersburg, 192242

References

  1. Chen N. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020:395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7
  2. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(16):986. doi: 10.1001/jama.2020.2648
  3. Liao YC, Liang WG, Chen FW, et al. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J. Immunol. 2002;169(8):4288–97. doi: 10.4049/jimmunol.169.8.4288
  4. Mehta P. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England). 2020;395(10229): 1033–1034, 2020, doi: 10.1016/S0140-6736(20)30628-0
  5. Lee N. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003;348(20):1986–94. doi: 10.1056/NEJMoa030685
  6. Wu C. Risk factors associated with Acute Respiratory Distress Syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;323(14):1385. doi: 10.1001/jamainternmed.2020.0994
  7. Young BE. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488. doi: 10.1001/jama.2020.3204
  8. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet. Gastroenterol. Hepatol. 2020;5(6):529–530. doi: 10.1016/S2468-1253(20)30084-4
  9. Qu R. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J. Med. Virol. 2020;285:198-203. doi: 10.1002/jmv.25767
  10. Fan BE. Hematologic parameters in patients with COVID-19 infection. Am. J. Hematol. 2020;95(6):131–134. doi: 10.1002/ajh.25774.
  11. Aggarwal S, Gollapudi S, Yel L, Gupta AS. TNF-alpha-induced apoptosis in neonatal lymphocytes: TNF Rp55 expression and downstream pathways of apoptosis. Genes Immun. 2000;1(4): 271–9. doi: 10.1038/sj.gene.6363674
  12. Chang WJ, Lai HC, Earnest A, Kuperan P. Haematological parameters in severe acute respiratory syndrome. Clin. Lab. Haematol. 2005;27(1):15–20. doi: 10.1111/j.1365-2257.2004.00652.x
  13. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System. JAMA Cardiol. 2020;331(18):1564. doi: 10.1001/jamacardio.2020.1286
  14. Huang C. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
  15. Siyuan M, Zhiqiang Y, Yizhi P, Jing C. Experience and suggestion of medical practices for burns during the outbreak of COVID-19. Burns. 2020;46(4):749-735. doi: 10.1016/j.burns.2020.03.014
  16. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin. Chim. Acta. 2020;506:145–148. doi: 10.1016/j.cca.2020.03.022
  17. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18(4):844–847. doi: 10.1111/jth.14768
  18. Zajcev AA, Chernov SA, Kryukov EV, et al. Prakticheskij opyt vedeniya pacientov s novoj koronavirusnoj infekciej COVID-19 v stacionare (predvaritel’nye itogi i rekomendacii). Lechashchij vrach. 2020;6:74–79. (In Russ.)

Copyright (c) 2021 Zinoviev E.V., Manukovskiy V.A., Kostyakov D.V., Tsygan V.N., Apchel A.V., Soloshenko V.V., Pivovarova L.P., Ternovoy D.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies